Results 191 to 199 of about 6,247 (199)

TAPSE/PASP ratio as a prognostic marker in HFmrEF: a missed opportunity?

Heart and Vessels
Xiaoyan, Chen, Youai, Xie, Meiqing, Zhou
openaire   +2 more sources

Prevalence And Clinical Significance Of Systemic Inflammation In Hfpef And Hfmref

Journal of Cardiac Failure
Barry A. Borlaug, Cecile Holse, Mette Holme Jung, A. Michael Lincoff, Sharon Mulvagh, Jacob Stærk-Østergaard, Katherine Tuttle, Mark Petrie   +7 more
openaire   +1 more source

HFpEF and HFmrEF in acute heart failure: isolated diastolic dysfunction or alternative cardiac pathologies?

Internal and Emergency Medicine
Maria Giulia Bellicini
exaly  

Both HFpEF and HFmrEF should be included in calculating CHA2DS2-VASc score: A Taiwanese longitudinal cohort

Heart Rhythm
Sheng-Nan Chang, Cho-Kai Wu
exaly  

HFmrEF and HFpEF: Detecting Progression Before Deterioration.

JACC. Heart failure
Virginia, Anagnostopoulou, Abhinav, Sharma, Pierpaolo, Pellicori   +2 more
openaire   +1 more source

Communicating robustness and sex-specific benefit of SGLT2 inhibitors in HFpEF and HFmrEF

European Journal of Internal Medicine
Qiang, Li, Haixu, Hao, Xiaoxuan, Yue, Meng, An, Yun, Yue   +4 more
openaire   +2 more sources

Herzinsuffizienz mit eingeschränkter LVEF (HFrEF, HFmrEF)

openaire   +1 more source

Weitere Therapieoption: Finerenon wirkt bei HFmrEF und HFpEF

CardioVasc
openaire   +1 more source

Very long-term LVEF dynamics and prognosis in HFrEF and HFmrEF

2017
de Antonio, M, Lupon, J, Lopez-Ayerbe, J, Moliner, P, Domingo, M, Ferrer, E, Zamora, E, Vallejo, N, Gual, F, Teis, A, Junca, G, Troya, MI, Rodriguez, M, Gonzalez, B, Bayes-Genis, A   +14 more
openaire   +1 more source